These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31838973)

  • 1. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992.
    Am J Cardiol; 1993 Sep; 72(10):1D-84D. PubMed ID: 8105672
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial hypercholesterolemia--we must act boldly.
    Moodie D
    Congenit Heart Dis; 2014; 9(4):273-4. PubMed ID: 25099345
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
    Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E
    Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 9. Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing.
    Corral P; Aguilar Salinas CA; Matta MG; Zago V; Schreier L
    Curr Atheroscler Rep; 2023 Dec; 25(12):899-909. PubMed ID: 37921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
    Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
    Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and Treatment of Familial Hypercholesterolemia].
    Schöb M; Müller P; Gerth Y; Korte W; Rickli H; Brändle M; Bärlocher A; Bilz S
    Praxis (Bern 1994); 2018 Nov; 107(24):1345-1353. PubMed ID: 30482120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic screening and treatment in familial hypercholesterolemia].
    Leren TP; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1635-6. PubMed ID: 11446055
    [No Abstract]   [Full Text] [Related]  

  • 14. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolemia. There is a need for early detection and treatment.
    Bilheimer DW
    JAMA; 1987 Jan; 257(1):69-70. PubMed ID: 3783906
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.
    Safarova MS; Kullo IJ
    Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous familial hypercholesterolemia presenting as chylomicronemia syndrome.
    Rosenson RS; Najera SD; Hegele RA
    J Clin Lipidol; 2017; 11(1):294-296. PubMed ID: 28391899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical criteria versus DNA diagnosis in heterozygous familial hypercholesterolemia: Is molecular diagnosis superior to clinical diagnosis?
    Schuster H; Luft FC
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):331-2. PubMed ID: 9514399
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia.
    Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA
    J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.